Moderna CEO Stéphane Bancel has responded to the US government’s surprise support for an intellectual property waiver on COVID-19 vaccines by saying it will not hit his company’s earnings – and neither would it help ramp up manufacturing output globally.
The US government announced on 5 May its backing of India’s and South Africa’s moves to waive intellectual property (IP) rights via a World Trade Organization (WTO) agreement, in the hope that it could address an acute shortage of doses in middle and lower income countries